NSAIDs vs acetaminophen in knee and hip osteoarthritis: A systematic review regarding heterogeneity influencing the outcomes

Osteoarthritis and Cartilage

Volumn 19, Issue 8, 2011, Pages 921-929

  Verkleij, S P J ^a   Luijsterburg, P A J ^a   Bohnen, A M ^a   Koes, B W ^a   Bierma Zeinstra, S M A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acetaminophen; Heterogeneity; Meta analysis; NSAID; Osteoarthritis

Indexed keywords

ACECLOFENAC; CELECOXIB; DICLOFENAC; FLOCTAFENIC ACID; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

DOSE RESPONSE; DRUG EFFICACY; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ACETAMINOPHEN; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 79960334683     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.04.013     Document Type: Review

References (41)

1. Belo J.N., Bierma-Zeinstra S.M.A., Raaijmakers A.J., van der Wissel F. NHG-Standaard niet-traumatische knieproblemen bij volwassenen. Huisarts Wetensch 2008, 51:229-240.
2. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., Dieppe P., et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003, 62:1145-1155.
3. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007, 15:981-1000.
4. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000, 43:1905-1915.
5. Towheed T.E., Maxwell L., Judd M.G., Catton M., Hochberg M.C., Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006, CD004257.
6. Lee C., Straus W.L., Balshaw R., Barlas S., Vogel S., Schnitzer T.J. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum 2004, 51:746-754.
7. Zhang W., Jones A., Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004, 63:901-907.
8. Wegman A., van der Windt D., van Tulder M., Stalman W., de Vries T. Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. J Rheumatol 2004, 31:344-354.
9. Laine L., Smith R., Min K., Chen C., Dubois R.W. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006, 24:751-767.
10. Ong C.K., Lirk P., Tan C.H., Seymour R.A. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res 2007, 5:19-34.
11. Higgins J., Thompson S., Deeks J., Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002, 7:51-61.
12. Bjordal J.M., Ljunggren A.E., Klovning A., Slordal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 2004, 329:1317.
13. Vlad S.C., LaValley M.P., McAlindon T.E., Felson D.T. Glucosamine for pain in osteoarthritis: why do trial results differ?. Arthritis Rheum 2007, 56:2267-2277.
14. Pincus T., Koch G.G., Sokka T., Lefkowith J., Wolfe F., Jordan J.M., et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001, 44:1587-1598.
15. Bradley J.D., Katz B.P., Brandt K.D. Severity of knee pain does not predict a better response to an antiinflammatory dose of ibuprofen than to analgesic therapy in patients with osteoarthritis. J Rheumatol 2001, 28:1073-1076.
16. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34.
17. Higgins J., Altman D. Assessing risk of bias in included studies. Handbook for Systematic Reviews of Interventions (Version 501) 2008, The Cochrane Collaboration.
18. Verhagen A.P., de Vet H.C., de Bie R.A., Kessels A.G., Boers M., Bouter L.M., et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998, 51:1235-1241.
19. Bellamy N., Buchanan W.W. A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol 1986, 5:231-241.
20. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Assiocates, Hillsdale, NJ. 2nd edn.
21. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
22. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
23. Batlle-Gualda E., Roman Ivorra J., Martin-Mola E., Carbonell Abello J., Linares Ferrando L.F., Tornero Molina J., et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial. Osteoarthritis Cartilage 2007, 15:900-908.
24. Boureau F., Schneid H., Zeghari N., Wall R., Bourgeois P. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip. Ann Rheum Dis 2004, 63:1028-1034.
25. Bradley J.D., Brandt K.D., Katz B.P., Kalasinski L.A., Ryan S.I. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991, 325:87-91.
26. Case JP, Baliunas AJ, Block JA Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 2003, 163:169-178.
27. Geba G.P., Weaver A.L., Polis A.B., Dixon M.E., Schnitzer T.J., Vioxx A.C.T.G. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA 2002, 287:64-71.
28. Golden H.E., Moskowitz R.W., Minic M. Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. Am J Ther 2004, 11:85-94.
29. Lequesne M., Fannius J., Reginster J.Y., Verdickt W., du Laurier M.V. Floctafenin versus acetaminophen for pain control in patients with osteoarthritis in the lower limbs. Franco-Belgian Task Force. Rev Rhum Engl Ed 1997, 64:327-333.
30. Pincus T., Koch G., Lei H., Mangal B., Sokka T., Moskowitz R., et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis 2004, 63:931-939.
31. Pincus T. Clinical evidence for osteoarthritis as an inflammatory disease. Curr Rheumatol Rep 2001, 3:524-534.
32. Schnitzer T.J., Tesser J.R., Cooper K.M., Altman R.D. A 4-week randomized study of acetaminophen extended-release vs rofecoxib in knee osteoarthritis. Osteoarthritis Cartilage 2009, 17:1-7.
33. Schnitzer T.J., Weaver A.L., Polis A.B., Petruschke R.A., Geba G.P., Groups V-aV-S Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. J Rheumatol 2005, 32:1093-1105.
34. Shen H., Sprott H., Aeschlimann A., Gay R.E., Michel B.A., Gay S., et al. Analgesic action of acetaminophen in symptomatic osteoarthritis of the knee. Rheumatology (Oxford) 2006, 45:765-770.
35. Temple A.R., Benson G.D., Zinsenheim J.R., Schweinle J.E. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Clin Ther 2006, 28:222-235.
36. Williams H.J., Ward J.R., Egger M.J., Neuner R., Brooks R.H., Clegg D.O., et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993, 36:1196-1206.
37. Svensson O., Malmenas M., Fajutrao L., Roos E.M., Lohmander L.S. Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36. Ann Rheum Dis 2006, 65:781-784.
38. Scott-Lennox JA, McLaughlin-Miley C, Lennox RD, Bohlig AM, Cutler BL, Yan C, et al. Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis. Arthritis Rheum 2001, 44:1599-1607.
39. Barkin RL, Beckerman M, Blum SL, Clark FM, Koh EK, Wu DS Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?. Drugs Aging 2010, 27:775-789.
40. Stewart LA, Tierney JF To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002, 25:76-97.
41. Bierma-Zeinstra SMA, Verhagen AP. Osteoarthritis subpopulations and implications for clinical trial design. In press.